Comparative Safety and Effectiveness of Apixaban Dosing in Patients With Atrial Fibrillation and Severe CKD

被引：0
|
作者：
Xu, Yunwen [1 ]
Chang, Alex R. [2 ]
Inker, Lesley A. [3 ]
McAdams-DeMarco, Mara [4 ]
Grams, Morgan [1 ,4 ]
Shin, Jung-Im [1 ]
机构：
[1] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA
[2] Geisinger Hlth, Danville, PA USA
[3] Tufts Med CTR, Boston, MA USA
[4] NYU, Grossman Sch Med & Langone Hlth, New York, NY USA
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2022年 / 33卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
TH-PO896
引用
收藏
页码：305 / 305
页数：1
相关论文
共 50 条
  • [41] Safety and Effectiveness Outcomes between Apixaban Versus Vitamin K Antagonists in Atrial Fibrillation Patients on Dialysis
    Guo, Zongwen
    Wang, Yufan
    Ding, Xiaoli
    Lai, Jiying
    Chen, Yijian
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2024, 25 (09)
  • [42] Safety and Efficacy of Apixaban in the Treatment of Atrial Fibrillation
    Martin, Andrew
    Stewart, Ralph
    CLINICAL MEDICINE INSIGHTS-CARDIOLOGY, 2012, 6 : 103 - 109
  • [43] Comparative Effectiveness and Safety of Direct Oral Anticoagulants in Obese Patients with Atrial Fibrillation
    Briasoulis, Alexandros
    Mentias, Amgad
    Mazur, Alexander
    Alvarez, Paulino
    Leira, Enrique C.
    Vaughan Sarrazin, Mary S.
    CARDIOVASCULAR DRUGS AND THERAPY, 2021, 35 (02) : 261 - 272
  • [44] Comparative Effectiveness and Safety of Direct Oral Anticoagulants in Obese Patients with Atrial Fibrillation
    Alexandros Briasoulis
    Amgad Mentias
    Alexander Mazur
    Paulino Alvarez
    Enrique C. Leira
    Mary S. Vaughan Sarrazin
    Cardiovascular Drugs and Therapy, 2021, 35 : 261 - 272
  • [45] Comparison of dabigatran, rivaroxaban, and apixaban for effectiveness and safety in atrial fibrillation: a nationwide cohort study
    Rutherford, Ole-Christian W.
    Jonasson, Christian
    Ghanima, Waleed
    Soderdahl, Fabian
    Halvorsen, Sigrun
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2020, 6 (02) : 75 - 85
  • [46] Comparison of the Effectiveness and Safety of Apixaban, Dabigatran, Rivaroxaban, and Warfarin in Newly Diagnosed Atrial Fibrillation
    Hernandez, Inmaculada
    Zhang, Yuting
    Saba, Samir
    AMERICAN JOURNAL OF CARDIOLOGY, 2017, 120 (10): : 1813 - 1819
  • [47] Comparative Effectiveness and Safety Between Apixaban, Dabigatran, Edoxaban, and Rivaroxaban Among Patients With Atrial Fibrillation: A Multinational Population-Based Cohort Study
    Lau, Wallis C. Y.
    Torre, Carmen Olga
    Man, Kenneth K. C.
    Stewart, Henry Morgan
    Seager, Sarah
    Van Zandt, Mui
    Reich, Christian
    Li, Jing
    Brewster, Jack
    Lip, Gregory Y. H.
    Hingorani, Aroon D.
    Wei, Li
    Wong, Ian C. K.
    ANNALS OF INTERNAL MEDICINE, 2022, 175 (11) : 1515 - +
  • [48] Using primary care data to assess comparative effectiveness and safety of apixaban and rivaroxaban in patients with nonvalvular atrial fibrillation in the UK: an observational cohort study
    Jaksa, Ashley
    Gibbs, Liza
    Kent, Seamus
    Rowark, Shaun
    Duffield, Stephen
    Sharma, Manuj
    Kincaid, Lynne
    Ali, Ayad K.
    Patrick, Amanda R.
    Govil, Priya
    Jonsson, Pall
    Gatto, Nicolle
    BMJ OPEN, 2022, 12 (10):
  • [49] Meta-Analysis of Effectiveness and Safety of Oral Anticoagulants in Atrial Fibrillation With Focus on Apixaban
    Bai, Ying
    Shi, Xu-Bo
    Ma, Chang-Sheng
    Lip, Gregory Y. H.
    AMERICAN JOURNAL OF CARDIOLOGY, 2017, 120 (09): : 1689 - 1695
  • [50] Effectiveness and Safety of Apixaban Versus Warfarin in Obese Patients with Nonvalvular Atrial Fibrillation Enrolled in Medicare and Veteran Affairs
    Deitelzweig, Steve
    Sah, Janvi
    Kang, Amiee
    Russ, Cristina
    Preib, Madison
    Dhamane, Amol D.
    Ratiu, Anna
    Cato, Matthew
    Alfred, Tamuno
    Levi, Edi
    Di Fusco, Manuela
    AMERICAN JOURNAL OF CARDIOLOGY, 2022, 163 : 43 - 49
12345